Catalyst Wire Dossier Catalyst Wire Dossier

PRO-067 Ophthalmic Solution

PRO-067 ophthalmic solution · Laboratorios Sophia S.A de C.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO-067 Ophthalmic Solution, covering 2019-10-28 to 2019-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension [Phase 3]

See pricing